DTL
CCCC icon

Dynamic Technology Lab’s C4 Therapeutics CCCC Stock Holding History

Dynamic Technology Lab’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,476
Closed -$31K – 855
2025
Q2 		$31K Buy
+21,476
New +$31.2K ﹤0.01% 879
2023
Q3 		– Sell
-12,708
Closed -$35K – 984
2023
Q2 		$35K Buy
12,708
+529
+4% +$1.7K ﹤0.01% 933
2023
Q1 		$38K Buy
+12,179
New +$71.7K ﹤0.01% 1008
2022
Q3 		– Sell
-32,933
Closed -$248K – 1151
2022
Q2 		$248K Buy
32,933
+11,043
+50% +$97.2K 0.03% 837
2022
Q1 		$531K Buy
21,890
+9,930
+83% +$241K 0.06% 553
2021
Q4 		$385K Buy
+11,960
New +$473K 0.04% 709

Other funds holding CCCC

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dynamic Technology Lab's CCCC Position: Q3 2025 in Review

Dynamic Technology Lab sold out of C4 Therapeutics (CCCC) in Q3 2025, closing a stake of 21,476 shares — an estimated $31K sold.

Dynamic Technology Lab first reported a position in CCCC in Q4 2021 and held it in 6 quarters. The position peaked at $531K in Q1 2022. 97 funds tracked by Wall St. Rank hold CCCC as of Q3 2025.

  • Dynamic Technology Lab reported no remaining C4 Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 21,476 C4 Therapeutics shares in Q3 2025, an estimated $31K.
  • Dynamic Technology Lab first reported a position in C4 Therapeutics in Q4 2021 and held it in 6 quarters.
  • Dynamic Technology Lab's C4 Therapeutics position peaked at $531K in Q1 2022.
  • 97 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2025.

Based on Dynamic Technology Lab's 13F filing for Q3 2025, filed 13 Nov 2025.